Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription

Articles published in Thorax

Retrieve available abstracts of 32 articles:
HTML format
Text format

Single Articles

    January 2018
    Countrywide demonstration of adult protection derived from infant immunisation.
    Thorax. 2018 Jan 9. pii: thoraxjnl-2017-211099.
    PubMed     Text format    

  2. SAINT-CRIQ V, Villeret B, Bastaert F, Kheir S, et al
    Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway.
    Thorax. 2018;73:49-61.
    PubMed     Text format     Abstract available

    December 2017
  3. SARNA M, Lambert SB, Sloots TP, Whiley DM, et al
    Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort.
    Thorax. 2017 Dec 15. pii: thoraxjnl-2017-210233.
    PubMed     Text format     Abstract available

  4. JAMIESON K, Boyd S, Tan S, Wong D, et al
    Case-based discussion from the neonatal intensive care unit: a case of an intentional oesophageal intubation.
    Thorax. 2017 Dec 8. pii: thoraxjnl-2017-210717.
    PubMed     Text format     Abstract available

  5. FRAYMAN KB, Armstrong DS, Carzino R, Ferkol TW, et al
    The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
    Thorax. 2017;72:1104-1112.
    PubMed     Text format     Abstract available

    October 2017
  6. BLOOM CI, Nissen F, Douglas IJ, Smeeth L, et al
    Exacerbation risk and characterisation of the UK's asthma population from infants to old age.
    Thorax. 2017 Oct 26. pii: thoraxjnl-2017-210650.
    PubMed     Text format     Abstract available

  7. OKASHA O, Rinta-Kokko H, Palmu AA, Ruokokoski E, et al
    Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland.
    Thorax. 2017 Oct 7. pii: thoraxjnl-2017-210440.
    PubMed     Text format     Abstract available

    September 2017
  8. VERBANCK S, King GG, Zhou W, Miller A, et al
    The quantitative link of lung clearance index to bronchial segments affected by bronchiectasis.
    Thorax. 2017 Sep 2. pii: thoraxjnl-2017-210496.
    PubMed     Text format     Abstract available

    August 2017
  9. KORTEN I, Kieninger E, Klenja S, Mack I, et al
    Respiratory viruses in healthy infants and infants with cystic fibrosis: a prospective cohort study.
    Thorax. 2017 Aug 4. pii: thoraxjnl-2016-209553.
    PubMed     Text format     Abstract available

  10. MARSHALL H, Horsley A, Taylor CJ, Smith L, et al
    Detection of early subclinical lung disease in children with cystic fibrosis by lung ventilation imaging with hyperpolarised gas MRI.
    Thorax. 2017;72:760-762.
    PubMed     Text format     Abstract available

    April 2017
    Preterm respiratory disease in the modern era: the value of cohort studies.
    Thorax. 2017 Apr 7. pii: thoraxjnl-2016-209291.
    PubMed     Text format    

  12. SOMAYAJI R, Lam JC, Surette MG, Waddell B, et al
    Long-term clinical outcomes of 'Prairie Epidemic Strain' Pseudomonas aeruginosa infection in adults with cystic fibrosis.
    Thorax. 2017;72:333-339.
    PubMed     Text format     Abstract available

  13. STANOJEVIC S, McDonald A, Waters V, MacDonald S, et al
    Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.
    Thorax. 2017;72:327-332.
    PubMed     Text format     Abstract available

  14. BELL SC, Flume PA
    Treatment decisions for MRSA in patients with cystic fibrosis (CF): when is enough, enough?
    Thorax. 2017;72:297-299.
    PubMed     Text format    

    February 2017
  15. ALTON EW, Beekman JM, Boyd AC, Brand J, et al
    Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
    Thorax. 2017;72:137-147.
    PubMed     Text format     Abstract available

    January 2017
  16. SIMPSON SJ, Logie KM, O'Dea CA, Banton GL, et al
    Altered lung structure and function in mid-childhood survivors of very preterm birth.
    Thorax. 2017 Jan 24. pii: thoraxjnl-2016-208985.
    PubMed     Text format     Abstract available

  17. PRICKETT MH, Hauser AR, McColley SA, Cullina J, et al
    Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
    Thorax. 2017;72:40-47.
    PubMed     Text format     Abstract available

  18. BRUGHA R, Hall A, Bush A
    It ain't necessarily so: a surprising lower airway infection.
    Thorax. 2017;72:96-97.
    PubMed     Text format    

    November 2016
  19. GRAY D, Willemse L, Visagie A, Czovek D, et al
    Determinants of early-life lung function in African infants.
    Thorax. 2016 Nov 17. pii: thoraxjnl-2015-207401.
    PubMed     Text format     Abstract available

    September 2016
  20. DOYLE LW, Adams AM, Robertson C, Ranganathan S, et al
    Increasing airway obstruction from 8 to 18 years in extremely preterm/low-birthweight survivors born in the surfactant era.
    Thorax. 2016 Sep 6. pii: thoraxjnl-2016-208524.
    PubMed     Text format     Abstract available

  21. DUIJTS L
    Growing large and fast: is infant growth relevant for the early origins of childhood asthma?
    Thorax. 2016 Sep 6. pii: thoraxjnl-2016-209061.
    PubMed     Text format    

    July 2016
  22. POPOVIC M, Pizzi C, Rusconi F, Galassi C, et al
    Infant weight trajectories and early childhood wheezing: the NINFEA birth cohort study.
    Thorax. 2016 Jul 1. pii: thoraxjnl-2015-208208.
    PubMed     Text format     Abstract available

    June 2016
  23. MACLEAN JE, DeHaan K, Fuhr D, Hariharan S, et al
    Altered breathing mechanics and ventilatory response during exercise in children born extremely preterm.
    Thorax. 2016 Jun 3. pii: thoraxjnl-2015-207736.
    PubMed     Text format     Abstract available

    May 2016
  24. FINA A, Baque-Juston M, Guesmi M, Albertini M, et al
    Symptomatic accessory cardiac bronchus in an infant.
    Thorax. 2016 May 23. pii: thoraxjnl-2016-208407.
    PubMed     Text format    

  25. KANE M, Gonska T, Jensen R, Avolio J, et al
    Lung clearance index response in patients with CF with class III CFTR mutations.
    Thorax. 2016;71:476-7.
    PubMed     Text format    

  26. MAYER-HAMBLETT N, Boyle M, VanDevanter D
    Advancing clinical development pathways for new CFTR modulators in cystic fibrosis.
    Thorax. 2016;71:454-61.
    PubMed     Text format     Abstract available

    March 2016
  27. HAQ IJ, Gray MA, Garnett JP, Ward C, et al
    Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
    Thorax. 2016;71:284-7.
    PubMed     Text format     Abstract available

  28. HELTSHE SL, Goss CH, Thompson V, Sagel SD, et al
    Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.
    Thorax. 2016;71:223-9.
    PubMed     Text format     Abstract available

  29. QUON BS, Dai DL, Hollander Z, Ng RT, et al
    Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Thorax. 2016;71:216-22.
    PubMed     Text format     Abstract available

    February 2016
  30. ELBORN JS, Ramsey B, Wainwright C, Boyle M, et al
    Response to: 'Lumacaftor/ivacaftor for patients homozygous for Phe508del-CFTR: should we curb our enthusiasm?' by Jones and Barry.
    Thorax. 2016;71:185-6.
    PubMed     Text format    

  31. DENTICE RL, Elkins MR, Middleton PG, Bishop JR, et al
    A randomised trial of hypertonic saline during hospitalisation for exacerbation of cystic fibrosis.
    Thorax. 2016;71:141-7.
    PubMed     Text format     Abstract available

  32. HELTSHE SL, Goss CH
    Optimising treatment of CF pulmonary exacerbation: a tough nut to crack.
    Thorax. 2016;71:101-2.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Neonatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.